melotin
arrotex pharmaceuticals (nz) limited - melatonin 2mg; - modified release tablet - 2 mg - active: melatonin 2mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate methacrylic acid copolymer purified talc - indicated as a monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients aged 55 years and over.
circadin
neurim pharmaceuticals (1991) ltd, israel - melatonin - tablets prolonged release - melatonin 2 mg - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
vigisom
pharmacy retailing (nz) ltd t/a healthcare logistics - melatonin 2mg; ; - modified release tablet - 2 mg - active: melatonin 2mg excipient: ammonio methacrylate copolymer calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate purified talc - monotherapy for the short term treatment (up to 13 weeks) of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
melatonin mr apotex melatonin 2 mg modified release tablet blister pack
apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
twinlab melatonin 2mg modified-release tablets
tree of life uk ltd - melatonin - modified-release tablet - 2mg
icenia melatonin 2mg capsules
imported (bulgaria) - melatonin - oral capsule - 2mg
meladura 2 mg prolonged-release tablets
bluefish pharmaceuticals ab - melatonin - prolonged-release tablet - melatonin
apohealth melatonin sleep aid
arrotex pharmaceuticals (nz) limited - melatonin 2mg; - modified release tablet - 2 mg - active: melatonin 2mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate methacrylic acid copolymer purified talc - indicated as a monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients aged 55 years and over.
melatonin liquid
bioactive nutritional, inc. - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - melatonin 6 [hp_x] in 1 ml - for temporary relief of fatigue, irritability, insomnia, and exhaustion. for temporary relief of fatigue, irritability, insomnia, and exhaustion.
melatonin
apotheca company - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - melatonin 200 [hp_c] in 1 ml - indications: for temporary relief of symptoms related to sleep disorders, seasonal affective disorder, jet lag, and depression. indications: for temporary relief of symptoms related to sleep disorders, seasonal affective disorder, jet lag, and depression.